ArticleThe oncologist2025

Astellas article: UK multidisciplinary recommendations on use of combination first-line enfortumab vedotin▼ and pembrolizumab in advanced urothelial carcinoma.

Syed Hussain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.